A randomised comparison of parecoxib versus placebo for pain management following minor day stay gynaecological surgery

Anaesthesia and Intensive Care

Volumn 38, Issue 1, 2010, Pages 141-148

  Luscombe, K S ^a   McDonnell, N J ^a   Muchatuta, N A ^a   Paech, M J ^a,b   Nathan, E A ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Ambulatory; Analgesia; Cyclo oxygenase 2 inhibitors; Gynaecologica; Opioid; Pain; Postoperative; Surgery

Indexed keywords

ANTIINFLAMMATORY AGENT; FENTANYL; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PARECOXIB; PLACEBO; SODIUM CHLORIDE; TRAMADOL;

ADULT; ANALGESIA; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CURETTAGE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL IRRITATION; GENERAL ANESTHESIA; GYNECOLOGIC SURGERY; HEADACHE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYSTEROSCOPY; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MINOR SURGERY; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PREOPERATIVE CARE; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SCORING SYSTEM; SINGLE DRUG DOSE;

EID: 75749130262     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x1003800123     Document Type: Article

References (36)

1. Daniels SE, Talwalker S, Torri S, Snabes MC, Recker DP, Verburg KM. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. Obstet Gynecol 2002; 100:350-358.
2. Gan TJ, Joshi GP, Zhao SZ, Hanna DB, Cheung Ry, Chen C. Presurgical intravenous parecoxib sodium and followup oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. Acta Anaesthesiol Scand 2004; 48:1194-1207.
3. Tang J, Li S, White PF, Chen X, Wender RH, Quon R et al. Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology 2002; 96:1305-1309.
4. Hubbard RC, Naumann TM, Traylor L, Dhadda S. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesth 2003; 90:166-172.
5. Peck TE, Williams M, Hammond E. Pharmacology for anaesthesia and intensive care, 1st ed. London: Greenwich Medical Media Ltd 2000. p. 120-122.
6. Robert K. Pharmacology and physiology in anaesthetic practice, 3rd ed. Lippincott-Raven Publishers 1999.
7. Barton SF, Langeland FF, Snabes MC, LeComte D, Kuss ME, Dhadda SS et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology 2002; 97:306-314.
8. Desjardins PJ, Grossman EH, Kuss ME, Talwalker S, Dhadda S, Baum D et al. The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg 2001; 93:721-727.
9. Ng A, Temple A, Smith G, Emembolu J. Early analgesic effects of parecoxib versus ketorolac following laparoscopic sterilization: a randomized controlled trial. Br J Anaesth 2004; 92:846-849.
10. Padi SSV, Jain NK, Singh S, Kulkarni SK. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor. Eur J Pharmacol 2004; 491:69-76.
11. Barden J, Edwards JE, McQuay HJ, Moore RA. Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol 2003; 3:1.
12. Koppert W, Frotsch K, Huzurudin N, Boswald W, Griessinger N, Weisbach V et al. The effects of paracetamol and parecoxib on kidney function in elderly patients undergoing orthopedic surgery. Anesth Analg 2006; 103:1170-1176.
13. Group UMIP. New Medicines on the Market. In: UK Medicines Information 2002.
14. Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC. The analgesic efficacy of intramuscular parecoxib sodium in post-operative dental pain. J Am Dent Assoc 2004; 135:1578-1590.
15. Amabile CM, Spencer AP. Parecoxib for parenteral analgesia in postsurgical patients. Ann Pharmacother 2004; 38:882-886.
16. Beaussier M, Weickmans H, Paugam C, Lavazais S, Baechle JP, Goater P et al. A randomized, double-blind comparison between parecoxib sodium and propacetamol for parenteral postoperative analgesia after inguinal hernia repair in adult patients. Anesth Analg 2005; 100:1309-1315.
17. Bajaj P, Ballary CC, Dongre NA, Baliga VP, Desai AA. Role of parecoxib in pre-emptive analgesia: comparison of the efficacy and safety of pre- and postoperative parecoxib in patients undergoing general surgery. J Indian Med Assoc 2004; 102:272, 274, 276-278.
18. Myles PS, Hunt JO, Nightingale CE, Fletcher H, Beh T, Tanil D et al. Development and psychometric testing of a quality of recovery score after general anesthesia and surgery in adults. Anesth Analg 1999; 88:83-90.
19. Mendoza TR, Chen C, Brugger A, Hubbard R, Snabes M, Palmer SN et al. The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain 2004; 20:357-362.
20. Ilkjaer S, Nielsen PA, Bach LF, Wernberg M, Dahl JB. The effect of dextromethorphan, alone or in combination with ibuprofen, on postoperative pain after minor gynaecological surgery. Acta Anaesthesiol Scand 2000; 44:873-877.
21. Piston D, Wang S, Feng y, ye y, Zhou J, Jiang K et al. The role of cyclooxygenase-2/prostanoid pathway in visceral pain induced liver stress response in rats. Chin Med J (Engl) 2007; 120:1813-1819.
22. Sarkar S, Hobson AR, Hughes A, Growcott J, Woolf CJ, Thompson DG et al. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology 2003; 124:18-25.
23. Shin S-W, Sandner-Kiesling A, Eisenach JC. Systemic, but not intrathecal ketorolac is antinociceptive to uterine cervical distension in rats. Pain 2003; 105:109-114.
24. Martin F, Fletcher D, Chauvin M, Bouhassira D. Constitutive cyclooxygenase-2 is involved in central nociceptive processes in humans. Anesthesiology 2007; 106:1013-1018.
25. Niruthisard S, Werawataganon T, Bunburaphong P, Ussawanophakiat M, Wongsakornchaikul C, Toleb K. Improving the analgesic efficacy of intrathecal morphine with parecoxib after total abdominal hysterectomy. Anesth Analg 2007; 105:822-824.
26. Bikhazi GB, Snabes MC, Bajwa ZH, Davis DJ, LeComte D, Traylor L et al. A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy. Am J Obstet Gynecol 2004; 191:1183-1191.
27. Daniels SE, Grossman EH, Kuss ME, Talwalker S, Hubbard RC. A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model. Clin Ther 2001; 23:1018-1031.
28. Malan TP Jr, Gordon S, Hubbard R, Snabes M. The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery. Anesth Analg 2005; 100:454-460.
29. Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, Cippolle M, Schuller R et al. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. Anesth Analg 2004; 98:336-342.
30. Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC. Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery. J Oral Maxillofac Surg 2003; 61:1030-1037.
31. Kranke P, Morin AM, Roewer N, Eberhart LH. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg 2004; 99:797-806.
32. Suthisisang C, Poolsup N, Kittikulsuth W, Pudchakan P, Wiwatpanich P. Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis. Ann Pharmacother 2007; 41:1782-1791.
33. Aldington S, Shirtcliffe P, Weatherall M, Beasley R. Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. N Z Med J 2005; 118:U1755.
34. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005; 352:1081-1091.
35. Schug SA, Joshi GP, Camu F. Parecoxib - getting to the heart of the matter. Anaesthesia 2007; 62:291-292.
36. Schug SA, Joshi GP, Camu F, Pan S, Cheung R. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data. Anesth Analg 2009; 108:299-307.